$85.30
Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
IOSP or AIQUY: Which Is the Better Value Stock Right Now?
IOSP: What does Argus have to say about IOSP?
Who Is the Right Buyer for Specialty Chemicals Maker Innospec?
Overview
52-week range
$66
$92
74% of range
Avg surprise (last 3)
+4.0%
Avg reaction (last 2)
+0.1%
50% positive
Latest IV / EM
33%
EM ±7.6% · $85 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $1.05 | $1.02 | +2.9% | -26.1% | -1.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.52 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $1.26 | $1.17 | +7.7% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $1.42 | $1.40 | +1.4% | — | +1.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $1.33 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $1.24 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $1.65 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $1.57 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $1.16 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | AMC | $1.05 | $1.26 | -16.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $453M | — | $442M | $440M | $441M | — | $443M | $435M |
| Cost of revenue | $330M | — | $325M | $316M | $316M | — | $319M | $308M |
| Gross profit | $124M | — | $117M | $123M | $125M | — | $124M | $127M |
| Operating income | $36M | — | $6M | $34M | $42M | — | $46M | $41M |
| Net income | $30M | — | — | — | $33M | — | — | — |
| EPS (diluted) | $1.22 | — | $0.52 | $0.94 | $1.31 | — | $1.33 | $1.24 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $289M | $292M | $271M | $267M | $300M | $289M | $304M | $240M |
| Inventory | $322M | $329M | $345M | $337M | $315M | $301M | $319M | $314M |
| Total current assets | $999M | $1.00B | $989M | $970M | $977M | $957M | $966M | $877M |
| Total assets | $1.82B | $1.83B | $1.80B | $1.81B | $1.77B | $1.73B | $1.80B | $1.70B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $468M | $500M | $496M | $505M | $509M | $519M | $550M | $504M |
| Total equity | $1.34B | $1.33B | $1.30B | $1.30B | $1.26B | $1.21B | $1.24B | $1.19B |